BE899366A - TOPICAL PHARMACEUTICAL COMPOSITIONS BASED ON MECLOPHENAMIC ACID. - Google Patents

TOPICAL PHARMACEUTICAL COMPOSITIONS BASED ON MECLOPHENAMIC ACID.

Info

Publication number
BE899366A
BE899366A BE6/47951A BE6047951A BE899366A BE 899366 A BE899366 A BE 899366A BE 6/47951 A BE6/47951 A BE 6/47951A BE 6047951 A BE6047951 A BE 6047951A BE 899366 A BE899366 A BE 899366A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
compositions based
topical pharmaceutical
meclophenamic acid
meclophenamic
Prior art date
Application number
BE6/47951A
Other languages
French (fr)
Inventor
S C Belsole
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BE899366A publication Critical patent/BE899366A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention a pour objet des compositions pharmaceutiques topiquement actives, leur production et leur application pharmacologique. Ces compositions consistent en un gel clair non aqueux stable comprenant environ 3 à 10 % en poids d'acide méclophénamique, un ester de polyéthylène glycol, une huile de lanoline hydrosoluble un agent épaississant et un alcool.The subject of the present invention is topically active pharmaceutical compositions, their production and their pharmacological application. These compositions consist of a stable, nonaqueous clear gel comprising approximately 3 to 10% by weight of meclophenamic acid, a polyethylene glycol ester, a water-soluble lanolin oil, a thickening agent and an alcohol.

BE6/47951A 1983-04-18 1984-04-06 TOPICAL PHARMACEUTICAL COMPOSITIONS BASED ON MECLOPHENAMIC ACID. BE899366A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48597383A 1983-04-18 1983-04-18

Publications (1)

Publication Number Publication Date
BE899366A true BE899366A (en) 1984-10-08

Family

ID=23930121

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6/47951A BE899366A (en) 1983-04-18 1984-04-06 TOPICAL PHARMACEUTICAL COMPOSITIONS BASED ON MECLOPHENAMIC ACID.

Country Status (8)

Country Link
AU (1) AU560035B2 (en)
BE (1) BE899366A (en)
CA (1) CA1229554A (en)
DE (1) DE3414377A1 (en)
FR (1) FR2544198B1 (en)
GB (1) GB2138287B (en)
NL (1) NL8400933A (en)
NZ (1) NZ207874A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1216233B (en) * 1986-07-02 1990-02-22 Menarini Sas USE OF THE PHARMACEUTICAL FORM 'GEL' CONTAINING N (2,6 DICHLORO M TOLIL) ANTRANILIC ACID (MECLOFENAMIC ACID) APPLICABLE IN THERAPY FOR TOPICAL USE.
WO1988001166A1 (en) * 1986-08-18 1988-02-25 Biota Scientific Management Pty Ltd Stimulation of angiogenesis and promotion of endothelialisation
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607316A (en) * 1975-07-04 1977-01-06 Gaba Ag ORAL AND DENTAL CARE PRODUCTS.
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
NL175882C (en) * 1977-03-28 Procter & Gamble PHARMACEUTICAL PREPARATION CONTAINING AN ANTI-INFLAMMATORY COMPOUND.
JPS5826815A (en) * 1981-08-10 1983-02-17 Ikeda Mohandou:Kk Nonsteroid antiphlogistic ointment and its preparation

Also Published As

Publication number Publication date
CA1229554A (en) 1987-11-24
NZ207874A (en) 1987-01-23
AU2514884A (en) 1984-10-25
GB2138287A (en) 1984-10-24
AU560035B2 (en) 1987-03-26
FR2544198A1 (en) 1984-10-19
NL8400933A (en) 1984-11-16
FR2544198B1 (en) 1987-11-20
DE3414377A1 (en) 1984-11-15
GB2138287B (en) 1986-03-05

Similar Documents

Publication Publication Date Title
ES8500738A1 (en) Topical anti-inflammatory compositions.
FR2540726B1 (en) ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE, THEIR PREPARATION AND THEIR USES
FR2356424A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON PHOPHONOFORMIC ACID USEFUL IN THE FIGHT AGAINST VIRAL INFECTIONS
DE3851152D1 (en) CYCLOSPORINE EYE PRODUCTS.
FR2439182A1 (en) NOVEL CYCLOPEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
TNSN96024A1 (en) NEW PHARMACEUTICAL COMBINATION
FR2392971A1 (en) PROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND MEDICINAL PRODUCT CONTAINING SUCH SUBSTANCES
CA2179682A1 (en) Pharmaceutical, orally applicable composition
ES2171525T3 (en) PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING PROPIONIC ACID (S) -2- (4-ISOBUTILFENIL).
BE899366A (en) TOPICAL PHARMACEUTICAL COMPOSITIONS BASED ON MECLOPHENAMIC ACID.
FR2374039A1 (en) COMPOSITIONS CONTAINING A DERIVATIVE OF SALICYLIC ACID AND MEDICINAL APPLICATIONS
FR2445329A1 (en) 11-BROMO-14-OXO-15-HYDROXY-IMINO-E-HOMO-EBURNANE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
FR2363324A1 (en) AQUEOUS OR HYDROALCOOLIC STABLE SOLUTIONS OF PERFUMED ESSENCES OR OIL SOLUBLE MEDICINAL PRODUCTS
FR2358890A1 (en) NEW ARYL TRIFLUOROETHYLAMINES, THEIR METHODS OF OBTAINING AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING
FR2422638A1 (en) NEW DERIVATIVES OF 3,3-DICHLORO-2-AZETIDINONE, USEFUL IN PARTICULAR AS ANTI-INFLAMMATORY AGENTS
FR2446279A1 (en) CIS- AND TRANS-3-ARYLOXY-4-HYDROXYPYRROLIDINES AND DERIVATIVES THEREOF, ESPECIALLY USEFUL IN VETERINARY MEDICINE AS ANTIDEPRESSANTS
FR2361387A1 (en) DERMATOLOGICAL COMPOSITION
BE813153A (en) COMPOSITIONS OF OIL-FREE PHARMACEUTICAL CREAMS
BE901963A (en) DOSED FORM OF ETOPOSIDE FOR ORAL USE.
FR2361883A2 (en) AMIDES OF PYRROLIDINO ETHYL AMINE USED IN PULMONARY THERAPEUTICS
FR2433019A1 (en) NOVEL THIOPHENECARBOXAMIDOALKYLMERCAPTANS, USEFUL IN PARTICULAR AS MUCOLYTICS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2422404A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON 2,4-DIAMINO-5-BENZYLPYRIMIDINE AND A SULFAMIDE; AND THEIR PREPARATION
LU81501A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TRIMETHOPRIME, AS WELL AS N-ETHYL-GAMMA-PYRIDONE-3-CARBOXYLIC ACID DERIVATIVES
FR2429017A1 (en)
FR2567756B1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING ACETYL-10 TRIACETOXY-1,8,9 ANTHRACENE AS ACTIVE INGREDIENT

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: WARNER-LAMBERT CY

Effective date: 19900430